399 related articles for article (PubMed ID: 33845756)
21. [Long-term prognosis of serum and urine n-terminal proBNP levels and glomerular filtration rate in heart failure patients].
Cortés R; Rivera M; Martínez-Dolz L; Jordán A; Roselló-Lletí E; Miró V; Portolés M
Med Clin (Barc); 2010 Mar; 134(7):296-302. PubMed ID: 20036402
[TBL] [Abstract][Full Text] [Related]
22. Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.
van Peet PG; de Craen AJ; Gussekloo J; de Ruijter W
Age (Dordr); 2014 Jun; 36(3):9660. PubMed ID: 24807464
[TBL] [Abstract][Full Text] [Related]
23. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
24. Increased serum level of N-terminal Pro-B-type natriuretic peptide as a possible biomarker of cardiovascular risk in psoriatic patients.
Pietrzak A; Bartosinska J; Blaszczyk R; Chodorowska G; Brzozowski W; Hercogova J; Donica H; Lotti T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):1010-4. PubMed ID: 24735175
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).
Everett BM; Ridker PM; Cook NR; Pradhan AD
Am J Cardiol; 2015 Aug; 116(4):532-7. PubMed ID: 26081066
[TBL] [Abstract][Full Text] [Related]
26. Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study.
Ebihara K; Yamagishi K; Umesawa M; Muraki I; Cui R; Imano H; Kubota Y; Hayama-Terada M; Shimizu Y; Ohira T; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H;
J Atheroscler Thromb; 2020 Aug; 27(8):751-760. PubMed ID: 31932552
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
[TBL] [Abstract][Full Text] [Related]
28. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
Juraschek SP; Daya N; Appel LJ; Miller ER; Matsushita K; Michos ED; Windham BG; Ballantyne CM; Selvin E
J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355
[TBL] [Abstract][Full Text] [Related]
29. Serial measurements of N-terminal pro-brain natriuretic peptide in patients with coronary heart disease.
Dallmeier D; Pencina MJ; Rajman I; Koenig W; Rothenbacher D; Brenner H
PLoS One; 2015; 10(1):e0117143. PubMed ID: 25629613
[TBL] [Abstract][Full Text] [Related]
30. Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.
Cortés R; Rivera M; Salvador A; Bertomeu V; de Burgos FG; Roselló-Lletí E; Portolés M; Payá R; Martínez-Dolz L; Climent V
Heart; 2007 Aug; 93(8):957-62. PubMed ID: 17488774
[TBL] [Abstract][Full Text] [Related]
31. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
Eggers KM; Venge P; Lind L
Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
[TBL] [Abstract][Full Text] [Related]
33. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
Klein Hesselink EN; van der Horst-Schrivers ANA; van der Horst ICC; Bakker SJL; Muller Kobold AC; Brouwers AH; de Bock GH; Gietema JA; Dullaart RPF; Links TP; Lefrandt JD
Clin Biochem; 2017 Aug; 50(12):696-702. PubMed ID: 28242284
[TBL] [Abstract][Full Text] [Related]
34. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
[TBL] [Abstract][Full Text] [Related]
35. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
[TBL] [Abstract][Full Text] [Related]
36. Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.
Linssen GC; Damman K; Hillege HL; Navis G; van Veldhuisen DJ; Voors AA
Circulation; 2009 Jul; 120(1):35-41. PubMed ID: 19546389
[TBL] [Abstract][Full Text] [Related]
37. Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery: A Cohort Study.
Duceppe E; Patel A; Chan MTV; Berwanger O; Ackland G; Kavsak PA; Rodseth R; Biccard B; Chow CK; Borges FK; Guyatt G; Pearse R; Sessler DI; Heels-Ansdell D; Kurz A; Wang CY; Szczeklik W; Srinathan S; Garg AX; Pettit S; Sloan EN; Januzzi JL; McQueen M; Buse GL; Mills NL; Zhang L; Sapsford R; Paré G; Walsh M; Whitlock R; Lamy A; Hill S; Thabane L; Yusuf S; Devereaux PJ
Ann Intern Med; 2020 Jan; 172(2):96-104. PubMed ID: 31869834
[TBL] [Abstract][Full Text] [Related]
38. Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort.
Campbell DJ; Gong FF; Jelinek MV; Castro JM; Coller JM; McGrady M; Boffa U; Shiel L; Wang BH; Liew D; Wolfe R; Stewart S; Owen AJ; Krum H; Reid CM; Prior DL
Eur J Heart Fail; 2019 Apr; 21(4):449-459. PubMed ID: 30656792
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
Folsom AR; Lutsey PL; Heckbert SR; Poudel K; Basu S; Hoogeveen RC; Cushman M; Ballantyne CM
J Thromb Haemost; 2018 Oct; 16(10):1964-1972. PubMed ID: 30007116
[TBL] [Abstract][Full Text] [Related]
40. NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study.
van Peet PG; Drewes YM; de Craen AJ; Gussekloo J; de Ruijter W
PLoS One; 2013; 8(11):e81400. PubMed ID: 24278434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
